Updated:
Rita Allen Foundation
The Rita Allen Foundation was established in 1953 by Charles Allen Jr., co-founder of the investment bank Allen & Company, and his sister Rita Allen Cassel, a...
Rita Allen Foundation
The Rita Allen Foundation was established in 1953 by Charles Allen Jr., co-founder of the investment bank Allen & Company, and his sister Rita Allen Cassel, a Broadway producer. Their pooled family wealth created a grantmaking institution that lay largely dormant until 1976, when it launched the Rita Allen Scholars program—one of the first philanthropic fellowships designed exclusively for early-career biomedical researchers. The program was shaped by direct input from leading scientists and initially focused on cancer, immunology, and neuroscience; it later expanded to include a dedicated pain research award in 2009. The Foundation hired its first CEO, Elizabeth Good Christopherson, and opened its Princeton office that same year, signaling a shift from a quiet family vehicle into an actively managed philanthropic enterprise. Unlike a traditional foundation that distributes grants across a broad portfolio, the Rita Allen Foundation operates as a concentrated venture-philanthropy platform. It places multiyear bets on individual scientists—called Rita Allen Scholars—at a stage when they have demonstrated unusual promise but lack the preliminary data required by the National Institutes of Health or major disease foundations. The Foundation's program architecture now spans two pillars: the legacy Scholars program in biomedical research, and a Civic Science initiative that funds networks and fellows working to reshape how science engages with communities, media, and democratic institutions. Through the Civic Science Fellows program, launched in partnership with the Kavli Foundation and other science funders, the Foundation has backed embedded fellows at newsrooms, universities, and community organizations across the United States. The Foundation's board reflects its investment- banking lineage and its later- stage institutionalization. Andrew K. Golden, the former president of Princeton University's endowment (PRINCO), sits on the board and also serves as a director of The Park Agency, the family office for the Kennedy family (per Altss research). The Foundation maintains a single office in Princeton and operates with a lean staff supporting CEO Christopherson. Its grantmaking vehicles include the annual Rita Allen Foundation Award in Pain, the core Scholars awards, and the Civic Science Fellows program, which placed its fourth cohort of fellows with host institutions across the United States starting September 2026. The Foundation's structural differentiator is the architecture of its scholar selection. It relies on a Scientific Advisory Committee of active investigators—several of whom are former Rita Allen Scholars themselves—to identify and nominate candidates. This closed-loop, peer-nomination model departs from the open-call format common at larger foundations. By concentrating its capital on a curated pipeline of early-stage investigators and coupling that with a growing civic-science practice, the Foundation has built a dual-use philanthropic engine: it seeds biomedical discovery while shaping the public conditions under which that science is understood and funded.
General information
Firm type
Endowment / Foundation
Year founded
1953
Location
Region
North America
Country
United States
City
Princeton
Corporate office
92 Nassau Street, 3rd Floor, Princeton, NJ 08542, United States
Principals
Elizabeth Good Christopherson
President and Chief Executive Officer
Charles Allen Jr.
Founder
Rita Allen Cassel
Founder
Milton Cassel
Former President
Andrew K. Golden
Board Member, former President of PRINCO
Sector focus
Frequently asked questions
How does the Rita Allen Foundation source its biomedical scholars?
The Foundation uses a peer- nomination model. Its Scientific Advisory Committee—composed of active researchers, many of them former Rita Allen Scholars—identifies early-career scientists working in cancer, immunology, neuroscience, and pain. The committee evaluates candidates based on the novelty of their work and their potential to produce breakthroughs before conventional funders would step in. This closed-loop process results in a highly curated cohort each year.
What is the Foundation's relationship to Allen & Company?
The Rita Allen Foundation was founded by Charles Allen Jr., the co-founder of the investment bank Allen & Company, and his sister Rita Allen Cassel. The Foundation's original corpus was built from the personal wealth of the Allen and Cassel families. Today the Foundation operates independently as a grantmaking institution with its own board, though its investment- banking lineage is reflected in board-level ties such as Andrew K. Golden's presence both at the Foundation and at The Park Agency.
Does the Foundation make direct investments or only philanthropic grants?
The Foundation is structured as a philanthropic grantmaker, not a venture capital firm. Its capital goes to multiyear fellowship awards for individual scientists and to programmatic grants for its Civic Science initiatives. While the Foundation describes its approach as 'venture philanthropy,' it does not take equity positions or make for-profit investments.
Who oversees the investment of the Foundation's endowment?
The Foundation does not publicly disclose the size of its endowment or the identity of its outsourced chief investment officer. Board member Andrew K. Golden brings deep endowment-management experience from his tenure as president of PRINCO, Princeton University's investment company, but his precise role in Foundation investment decisions has not been detailed publicly.
How does the Civic Science Fellows program differ from the legacy Scholars program?
The Scholars program funds laboratory-based biomedical researchers at universities and research institutes. The Civic Science Fellows program, launched in partnership with the Kavli Foundation and other funders, places fellows in newsrooms, community organizations, and academic centers to build bridges between science and society. It emphasizes network-building and cross-sector collaboration rather than bench science.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: